Found 13 matching trials
Study of KYV-101 Anti-CD19 CAR T Therapy in Adult Dermatomyositis
PHASE1The goal of this clinical trial is to characterize to understand the effect...
Location
Stanford University
CARTIMMUNE: Study of Patients With Autoimmune Diseases Receiving KYV-101
PHASE1The purpose of this study is to assess the safety, tolerability, and clinic...
Status
Active Not Recruiting
Location
Hospital of the Universithy of Pennsylvania
A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis
PHASE1A Study of Anti-CD19 Chimeric Antigen Receptor T Cell Therapy in Subjects w...
Location
Stanford Multiple Sclerosis Center
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
PHASE2A Study of the Anti-CD 19 Chimeric Antigen Receptor T Cell Therapy for Pati...
Location
Ronald Reagan UCLA Medical Center
Comparison of B-cell Depletion by Rituximab and Anti-CD 19 CAR-T Therapy in Patients With Rheumatoid Arthritis
PHASE1The goal of this phase I/II clinical trial is to compare B-cell depletion b...
Status
Active Not Recruiting
Location
Charité - Universitätsmedizin Berlin
KYSA-3: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis
PHASE1A Study of Anti-CD19 Chimeric Antigen Receptor T Cell Therapy for Subjects ...
Status
Active Not Recruiting
Location
Charite- Universitätsklinikum Berlin
KYSA-5: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Systemic Sclerosis
PHASE1A Study of Anti-CD19 Chimeric Antigen Receptor T Cell Therapy for Subjects ...
Status
Active Not Recruiting
Location
Stanford University Medical Center
KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis
PHASE1A Study of Anti-CD19 Chimeric Antigen Receptor T Cell Therapy for Subjects ...
Status
Active Not Recruiting
Location
Stanford University Medical Center
A Study of KYV-101, a CD19 CAR T Cell Therapy, in Participants With Treatment Refractory Progressive Multiple Sclerosis
PHASE1The goal of this study is to test a drug called KYV-101 in people who have ...
Status
Active Not Recruiting
Location
University of California, San Francisco, Multiple Sclerosis Center
A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
N/AThe purpose of this long-term follow-up (LTFU) study is to collect delayed ...
Location
University of Colorado, Denver